SilverCrest Metals
SILV
Cars.com
CARS
Halozyme Therapeutics
HALO
Lantheus
LNTH
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
ACN Accenture
- 361.390
- -0.240-0.07%
Trading Dec 26 15:34 ET
226.04BMarket Cap30.29P/E (TTM)
361.950High359.070Low550.88KVolume360.690Open361.630Pre Close198.83MTurnover0.09%Turnover Ratio31.59P/E (Static)625.48MShares382.76752wk High7.74P/B225.41BFloat Cap276.34352wk Low5.35Dividend TTM623.73MShs Float397.211Historical High1.48%Div YieldTTM0.80%Amplitude7.976Historical Low360.929Avg Price1Lot Size
Accenture Key Stats
Quarterly+Annual
YOY
| (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.03%17.69B | 1.22%64.9B | 2.63%16.41B | -0.59%16.47B | -0.09%15.8B | 3.03%16.22B | 4.09%64.11B | 3.64%15.99B | 2.51%16.56B | 5.10%15.81B |
| Operating revenue | 9.03%17.69B | 1.22%64.9B | 2.63%16.41B | -0.59%16.47B | -0.09%15.8B | 3.03%16.22B | 4.09%64.11B | 3.64%15.99B | 2.51%16.56B | 5.10%15.81B |
| Cost of revenue | 10.12%11.87B | 0.82%43.73B | 2.45%11.07B | -0.61%10.97B | -0.53%10.92B | 2.03%10.78B | 3.55%43.38B | 3.11%10.8B | 1.77%11.04B | 4.34%10.98B |
| Gross profit | 6.88%5.82B | 2.08%21.16B | 3.01%5.34B | -0.55%5.5B | 0.90%4.88B | 5.05%5.45B | 5.23%20.73B | 4.76%5.18B | 4.03%5.53B | 6.87%4.83B |
| Operating expense | -0.30%2.87B | -2.98%11.57B | -8.72%2.98B | -9.53%2.87B | -2.01%2.83B | 11.18%2.88B | 15.36%11.92B | 22.06%3.27B | 16.90%3.17B | 17.37%2.89B |
| Selling and administrative expenses | 4.77%2.87B | 2.48%11.13B | 2.90%2.88B | -1.16%2.79B | 2.68%2.72B | 5.80%2.74B | 5.07%10.86B | 4.44%2.8B | 4.10%2.82B | 7.45%2.65B |
| -Selling and marketing expense | 5.92%1.81B | 4.01%6.85B | 1.44%1.76B | 0.68%1.75B | 4.32%1.63B | 10.31%1.71B | 7.76%6.58B | 9.64%1.73B | 4.68%1.74B | 10.51%1.56B |
| -General and administrative expense | 2.88%1.06B | 0.13%4.28B | 5.27%1.12B | -4.10%1.04B | 0.30%1.09B | -0.91%1.03B | 1.18%4.28B | -3.02%1.07B | 3.20%1.08B | 3.31%1.08B |
| Other operating expenses | ---- | -58.76%438.44M | -77.55%105.95M | -77.68%77.42M | -52.78%115.41M | --139.66M | --1.06B | --471.88M | --346.87M | --244.39M |
| Operating profit | 14.96%2.95B | 8.92%9.6B | 23.04%2.35B | 11.51%2.63B | 5.24%2.05B | -1.09%2.56B | -5.95%8.81B | -15.66%1.91B | -9.37%2.36B | -5.68%1.94B |
| Net non-operating interest income expense | -47.44%45.99M | -8.41%213.29M | -66.97%28.48M | -40.01%42.36M | 42.30%54.96M | 133.76%87.49M | 10,748.56%232.88M | 744.01%86.22M | 2,224.89%70.61M | 1,078.59%38.63M |
| Non-operating interest income | -25.45%76.03M | -2.91%272.26M | -50.48%51.32M | -34.38%53.69M | 29.87%65.27M | 128.12%101.98M | 521.29%280.41M | 348.85%103.63M | 837.53%81.82M | 591.42%50.26M |
| Non-operating interest expense | 107.26%30.04M | 24.08%58.97M | 31.21%22.84M | 1.12%11.33M | -11.42%10.31M | 99.11%14.5M | 0.43%47.53M | 35.21%17.4M | -6.99%11.21M | 3.73%11.63M |
| Other net income (expense) | -9.79%-39.22M | -213.72%-109.81M | -23.92%-49.59M | -109.34%-18.85M | 84.43%-5.65M | -23.57%-35.72M | 157.19%96.56M | -19.65%-40.02M | 291.86%201.78M | -405.36%-36.3M |
| Special income (charges) | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Gain on sale of business | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -9.79%-39.22M | -213.72%-109.81M | -23.92%-49.59M | -109.34%-18.85M | 84.43%-5.65M | -23.57%-35.72M | 233.12%96.56M | -19.65%-40.02M | 2,373.10%201.78M | -405.36%-36.3M |
| Income before tax | 12.94%2.96B | 6.13%9.7B | 19.06%2.33B | 0.86%2.65B | 7.64%2.1B | 0.58%2.62B | -0.62%9.14B | -12.73%1.96B | 5.49%2.63B | -5.05%1.95B |
| Income tax | 5.34%639.06M | 6.76%2.28B | 11.43%613.9M | 15.37%673.02M | -2.44%386.54M | 0.22%606.67M | -3.24%2.14B | -0.30%550.92M | -13.62%583.35M | 0.84%396.22M |
| Net income | 15.23%2.32B | 5.94%7.42B | 22.05%1.72B | -3.27%1.98B | 10.22%1.71B | 0.69%2.01B | 0.21%7B | -16.79%1.41B | 12.59%2.05B | -6.45%1.55B |
| Net income continuous Operations | 15.23%2.32B | 5.94%7.42B | 22.05%1.72B | -3.27%1.98B | 10.22%1.71B | 0.69%2.01B | 0.21%7B | -16.79%1.41B | 12.59%2.05B | -6.45%1.55B |
| Minority interest income | 2.08%37.3M | 17.00%154.41M | -2.51%34.37M | 28.24%49.17M | 27.03%34.34M | 16.55%36.54M | 18.05%131.97M | 29.32%35.25M | 15.34%38.34M | 19.69%27.04M |
| Net income attributable to the parent company | 15.48%2.28B | 5.72%7.26B | 22.68%1.68B | -3.87%1.93B | 9.92%1.67B | 0.43%1.97B | -0.08%6.87B | -17.55%1.37B | 12.54%2.01B | -6.81%1.52B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 15.48%2.28B | 5.72%7.26B | 22.68%1.68B | -3.87%1.93B | 9.92%1.67B | 0.43%1.97B | -0.08%6.87B | -17.55%1.37B | 12.54%2.01B | -6.81%1.52B |
| Basic earnings per share | 15.92%3.64 | 6.15%11.57 | 23.39%2.69 | -3.46%3.07 | 9.92%2.66 | 0.64%3.14 | 0.28%10.9 | -17.11%2.18 | 12.77%3.18 | -6.20%2.42 |
| Diluted earnings per share | 15.81%3.59 | 6.22%11.44 | 23.72%2.66 | -3.49%3.04 | 10.04%2.63 | 0.65%3.1 | 0.56%10.77 | -17.31%2.15 | 12.90%3.15 | -5.91%2.39 |
| Dividend per share | 14.73%1.48 | 15.18%5.16 | 15.18%1.29 | 15.18%1.29 | 15.18%1.29 | 15.18%1.29 | 15.46%4.48 | 15.46%1.12 | 15.46%1.12 | 15.46%1.12 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |